Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 9, 2010, Pages 1423-1429

  El Hindy, Nicolai ^a   Adamzik, Michael ^a   Lambertz, Nicole ^a   Bachmann, Hagen S ^a   Worm, Karl ^a   Egensperger, Rupert ^a,b   Frey, Ulrich H ^a   Asgari, Siamak ^a   Sure, Ulrich ^a   Siffert, Winfried ^a   Sandalcioglu, I Erol ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

G protein; Genes; Glioblastoma multiforme; GNB3; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; DNA METHYLTRANSFERASE; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ALLELE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; GLIOBLASTOMA; GNB3 GENE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MGMT GENE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PROMOTER REGION; SURVIVAL RATE;

ALLELES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENOTYPE; GLIOBLASTOMA; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 77955487673     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0797-8     Document Type: Article

References (38)

1. PC Burger SB Green 1987 Patient age, histologic features, and length of survival in patients with glioblastoma multiforme Cancer 59 1617 1625 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X 1:STN:280:DyaL2s7lvFWktA%3D%3D 3030531
2. H Clar U Langsenlehner P Krippl W Renner A Leithner G Gruber G Hofmann B Yazdani-Biuki T Langsenlehner R Windhager 2008 A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients Breast Cancer Res Treat 111 449 452 10.1007/s10549-007-9808-0 1:CAS:528:DC%2BD1cXhtV2js7fO 17978878
3. M Dean T Fojo S Bates 2005 Tumour stem cells and drug resistance Nat Rev Cancer 5 275 284 10.1038/nrc1590 1:CAS:528:DC%2BD2MXivVarsL4%3D 15803154
4. T Demuth ME Berens 2004 Molecular mechanisms of glioma cell migration and invasion J Neurooncol 70 217 228 10.1007/s11060-004-2751-6 15674479
5. J Dunn A Baborie F Alam K Joyce M Moxham R Sibson D Crooks D Husband A Shenoy A Brodbelt H Wong T Liloglou B Haylock C Walker 2009 Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy Br J Cancer 101 124 131 10.1038/sj.bjc.6605127 1:CAS:528:DC%2BD1MXotVKgtLk%3D 19536096
6. A Eisenhardt W Siffert D Rosskopf M Musch M Mosters U Roggenbuck KH Jockel H Rubben G Lummen 2005 Association study of the G protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer World J Urol 23 279 286 10.1007/s00345-005-0006-6 1:CAS:528:DC%2BD28XnsFOi 16133558
7. ME Hegi AC Diserens T Gorlia MF Hamou N de Tribolet M Weller JM Kros JA Hainfellner W Mason L Mariani JE Bromberg P Hau RO Mirimanoff JG Cairncross RC Janzer R Stupp 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 10.1056/NEJMoa043331 1:CAS:528: DC%2BD2MXit1Wktro%3D 15758010
8. IM Hennig JA Laissue U Horisberger JC Reubi 1995 Substance-P receptors in human primary neoplasms: tumoral and vascular localization Int J Cancer 61 786 792 10.1002/ijc.2910610608 1:STN:280:DyaK2MzhtVSmtw%3D%3D 7790112
9. P Kleihues DN Louis BW Scheithauer LB Rorke G Reifenberger PC Burger WK Cavenee 2002 The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 61 215 225 11895036 discussion 226-9
10. D Krex B Klink C Hartmann A von Deimling T Pietsch M Simon M Sabel JP Steinbach O Heese G Reifenberger M Weller G Schackert 2007 Long-term survival with glioblastoma multiforme Brain 130 2596 2606 10.1093/brain/awm204 17785346
11. GF Lehnerdt P Franz A Bankfalvi S Grehl K Jahnke S Lang KW Schmid W Siffert UH Frey 2008 Association study of the G protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 17 3203 3207 10.1158/1055-9965.EPI-08-0616 1:CAS:528:DC%2BD1cXhtlCkurzI 18990763
12. M Mollemann M Wolter J Felsberg VP Collins G Reifenberger 2005 Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors Int J Cancer 113 379 385 10.1002/ijc.20575 15455350
13. H Ohgaki P Kleihues 2005 Epidemiology and etiology of gliomas Acta Neuropathol 109 93 108 10.1007/s00401-005-0991-y 15685439
14. H Ohgaki P Kleihues 2005 Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 479 489 1:CAS:528:DC%2BD2MXlvVSgsbg%3D 15977639
15. H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL Di Patre C Burkhard D Schuler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yasargil UM Lutolf P Kleihues 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 64 6892 6899 10.1158/0008-5472.CAN-04-1337 1:CAS:528: DC%2BD2cXotFalsrc%3D 15466178
16. D Rosskopf I Manthey C Habich M Kielbik A Eisenhardt C Nikula M Urban S Kohnen E Graf U Ravens W Siffert 2003 Identification and characterization of G beta 3s2, a novel splice variant of the G protein beta 3 subunit Biochem J 371 223 232 10.1042/BJ20021208 1:CAS:528:DC%2BD3sXitlCitrc%3D 12431187
17. OM Salazar P Rubin ML Feldstein R Pizzutiello 1979 High dose radiation therapy in the treatment of malignant gliomas: final report Int J Radiat Oncol Biol Phys 5 1733 1740 1:STN:280:DyaL3c7hsV2rsQ%3D%3D 231023
18. M Schaich L Kestel M Pfirrmann K Robel T Illmer M Kramer C Dill G Ehninger G Schackert D Krex 2009 A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients Ann Oncol 20 175 181 10.1093/annonc/mdn548 1:STN:280:DC%2BD1M%2Fns12hsg%3D%3D 18687982
19. SY Sheu R Gorges C Ensinger D Ofner NR Farid W Siffert KW Schmid 2005 Different genotype distribution of the GNB3 C825T polymorphism of the G protein beta3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell origin J Pathol 207 430 435 10.1002/path.1857 1:CAS:528:DC%2BD2MXhtlCks7nO 16178055
20. SY Sheu S Handke M Brocker-Preuss R Gorges UH Frey C Ensinger D Ofner NR Farid W Siffert KW Schmid 2007 The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours J Pathol 211 60 66 10.1002/path.2084 1:CAS:528:DC%2BD2sXhs1yqurc%3D 17136758
21. W Siffert 1996 G proteins, hypertension, and coronary heart disease-novel findings and hypotheses Kidney Blood Press Res 19 71 80 10.1159/000174047 1:CAS:528:DyaK28XlsVyisbo%3D 8871885
22. W Siffert 1996 Genetically fixed enhanced G protein activation in essential hypertension Kidney Blood Press Res 19 172 173 10.1159/000174067 1:CAS:528:DyaK28XmsFGqs70%3D 8887254
23. W Siffert 1998 G proteins and hypertension Kidney Blood Press Res 21 262 263 10.1159/000025871 1:CAS:528:DyaK1cXmtVSgt7Y%3D 9762850
24. W Siffert 2003 Effects of the G protein beta 3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on "A splice variant of the G protein beta 3-subunit implicated in disease states does not modulate ion channels" Physiol Genomics 13 81 84 1:CAS:528:DC%2BD3sXkt1ClsL0%3D 12700359
25. W Siffert P Forster KH Jockel DA Mvere B Brinkmann C Naber R Crookes PHA Du JT Epplen J Fridey BI Freedman N Muller D Stolke AM Sharma K Al Moutaery H Grosse-Wilde B Buerbaum T Ehrlich HR Ahmad B Horsthemke ED Du Toit A Tiilikainen J Ge Y Wang D Rosskopf, et al. 1999 Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals J Am Soc Nephrol 10 1921 1930 1:STN:280:DyaK1MvgsVOqtg%3D%3D 10477144
26. W Siffert D Rosskopf R Erbel 2000 Genetic polymorphism of the G protein beta3 subunit, obesity and essential hypertension Herz 25 26 33 10.1007/BF03044121 1:STN:280:DC%2BD3c7nvVantA%3D%3D 10713907
27. JR Simpson J Horton C Scott WJ Curran P Rubin J Fischbach S Isaacson M Rotman SO Asbell JS Nelson, et al. 1993 Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials Int J Radiat Oncol Biol Phys 26 239 244 1:STN:280:DyaK3s3lvFyqsQ%3D%3D 8387988
28. SK Singh ID Clarke T Hide PB Dirks 2004 Cancer stem cells in nervous system tumors Oncogene 23 7267 7273 10.1038/sj.onc.1207946 1:CAS:528: DC%2BD2cXns1ektL0%3D 15378086
29. JS Smith RB Jenkins 2000 Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications Front Biosci 5 D213 D231 10.2741/Smith 1:CAS:528:DC%2BD3cXht1Shsbo%3D 10702383
30. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011 1018 10.1016/S0140-6736(02)08091-1 1:CAS:528: DC%2BD38XisV2htro%3D 11937180
31. W Stummer U Pichlmeier T Meinel OD Wiestler F Zanella HJ Reulen 2006 Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 392 401 10.1016/S1470-2045(06)70665-9 1:CAS:528:DC%2BD28XjvFWlsb0%3D 16648043
32. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009
33. R Stupp ME Hegi WP Mason MJ van den Bent MJ Taphoorn RC Janzer SK Ludwin A Allgeier B Fisher K Belanger P Hau AA Brandes J Gijtenbeek C Marosi CJ Vecht K Mokhtari P Wesseling S Villa E Eisenhauer T Gorlia M Weller D Lacombe JG Cairncross RO Mirimanoff 2009 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459 466 10.1016/S1470-2045(09)70025-7 1:CAS:528:DC%2BD1MXlsVKhs74%3D 19269895
34. K Yamaguchi T Kugimiya T Miyazaki 2005 Substance P receptor in U373 MG human astrocytoma cells activates mitogen-activated protein kinases ERK1/2 through Src Brain Tumor Pathol 22 1 8 10.1007/s10014-005-0178-1 1:CAS:528:DC%2BD2MXhtFyiu7rJ 18095097
35. K Yamaguchi MD Richardson DD Bigner MM Kwatra 2005 Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCdelta Cancer Chemother Pharmacol 56 585 593 10.1007/s00280-005-1030-3 1:CAS:528:DC%2BD2MXhtVKqu7bL 16012865
36. XH Yao YF Ping JH Chen DL Chen CP Xu J Zheng JM Wang XW Bian 2008 Production of angiogenic factors by human glioblastoma cells following activation of the G protein coupled formylpeptide receptor FPR J Neurooncol 86 47 53 10.1007/s11060-007-9443-y 1:CAS:528:DC%2BD1cXisFCisLc%3D 17611713
37. XH Yao YF Ping JH Chen CP Xu DL Chen R Zhang JM Wang XW Bian 2008 Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G protein coupled formylpeptide receptor FPR J Pathol 215 369 376 10.1002/path.2356 1:CAS:528:DC%2BD1cXhtVKns77O 18523971
38. Y Zhou X Bian Y Le W Gong J Hu X Zhang L Wang P Iribarren R Salcedo OM Howard W Farrar JM Wang 2005 Formylpeptide receptor FPR and the rapid growth of malignant human gliomas J Natl Cancer Inst 97 823 835 10.1093/jnci/dji142 1:CAS:528:DC%2BD2MXkvVShur4%3D 15928303